Ocugen Inc (NASDAQ: OCGN) kicked off on Monday, down -3.90% from the previous trading day, before settling in for the closing price of $0.98. Over the past 52 weeks, OCGN has traded in a range of $0.36-$2.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 8.52% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 22.12%. With a float of $287.09 million, this company’s outstanding shares have now reached $290.26 million.
In an organization with 65 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.72%, operating margin of -531.15%, and the pretax margin is -532.51%.
Ocugen Inc (OCGN) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Ocugen Inc is 1.45%, while institutional ownership is 27.50%. The most recent insider transaction that took place on Nov 26 ’24, was worth 9,095. In this transaction Director of this company bought 10,000 shares at a rate of $0.91, taking the stock ownership to the 10,000 shares. Before that another transaction happened on Nov 22 ’24, when Company’s Director bought 25,000 for $0.91, making the entire transaction worth $22,848. This insider now owns 75,000 shares in total.
Ocugen Inc (OCGN) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.03 earnings per share (EPS), higher than consensus estimate (set at -0.06) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.12% per share during the next fiscal year.
Ocugen Inc (NASDAQ: OCGN) Trading Performance Indicators
Take a look at Ocugen Inc’s (OCGN) current performance indicators. Last quarter, stock had a quick ratio of 2.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 59.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.18, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.26 in one year’s time.
Technical Analysis of Ocugen Inc (OCGN)
Let’s dig in a bit further. During the last 5-days, its volume was 3.42 million. That was inferior than the volume of 6.01 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 67.13%. Additionally, its Average True Range was 0.07.
During the past 100 days, Ocugen Inc’s (OCGN) raw stochastic average was set at 8.03%, which indicates a significant decrease from 39.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.09% in the past 14 days, which was lower than the 71.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9610, while its 200-day Moving Average is $1.3026. However, in the short run, Ocugen Inc’s stock first resistance to watch stands at $0.9824. Second resistance stands at $1.0210. The third major resistance level sits at $1.0471. If the price goes on to break the first support level at $0.9177, it is likely to go to the next support level at $0.8916. Assuming the price breaks the second support level, the third support level stands at $0.8530.
Ocugen Inc (NASDAQ: OCGN) Key Stats
The company with the Market Capitalisation of 278.44 million has total of 291,320K Shares Outstanding. Its annual sales at the moment are 6,040 K in contrast with the sum of -63,080 K annual income. Company’s last quarter sales were recorded 1,140 K and last quarter income was -12,970 K.
